Geode Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $891K | Sell |
|
|||||
|
2025
Q1 | $1.38M | Buy |
|
|||||
|
2024
Q4 | $1.15M | Buy |
|
|||||
|
2024
Q3 | $3.59M | Buy |
|
|||||
|
2024
Q2 | $4.71M | Buy |
|
|||||
|
2024
Q1 | $3.51M | Buy |
|
|||||
|
2023
Q4 | $1.46M | Buy |
|
|||||
|
2023
Q3 | $1.07M | Sell |
|
|||||
|
2023
Q2 | $1.28M | Sell |
|
|||||
|
2023
Q1 | $4.24M | Buy |
|
|||||
|
2022
Q4 | $7.63M | Buy |
|
|||||
|
2022
Q3 | $7.93M | Buy |
|
|||||
|
2022
Q2 | $6.86M | Buy |
|
|||||
|
2022
Q1 | $12.2M | Sell |
|
|||||
|
2021
Q4 | $18.3M | Buy |
|
|||||
|
2021
Q3 | $23.8M | Sell |
|
|||||
|
2021
Q2 | $33.6M | Buy |
|
|||||
|
2021
Q1 | $30.8M | Buy |
|
|||||
|
2020
Q4 | $22.3M | Buy |
|
|||||
|
2020
Q3 | $27.8M | Buy |
|
|||||
|
2020
Q2 | $58.8M | Buy |
|
|||||
|
2020
Q1 | $12.5M | Buy |
|
|||||
|
2019
Q4 | $4.46M | Buy |
|
|||||
|
2019
Q3 | $2.65M | Buy |
|
|||||
|
2019
Q2 | $3.53M | Buy |
|
|||||
|
2019
Q1 | $4.22M | Buy |
|
|||||
|
2018
Q4 | $4.02M | Buy |
|
|||||
|
2018
Q3 | $4.89M | Buy |
|
|||||
|
2018
Q2 | $3.34M | Buy |
|
|||||
|
2018
Q1 | $3.79M | Sell |
|
|||||
|
2017
Q4 | $3.44M | Buy |
|
|||||
|
2017
Q3 | $4.78M | Buy |
|
|||||
|
2017
Q2 | $4.58M | Buy |
|
|||||
|
2017
Q1 | $3.71M | Buy |
|
|||||
|
2016
Q4 | $3.46M | Buy |
|
|||||
|
2016
Q3 | $4.51M | Buy |
|
|||||
|
2016
Q2 | $4.41M | Sell |
|
|||||
|
2016
Q1 | $4.19K | Buy |
|
|||||
|
2015
Q4 | $2.93M | Buy |
|
|||||
|
2015
Q3 | $2.47M | Buy |
|
|||||
|
2015
Q2 | $3.43M | Buy |
|
|||||
|
2015
Q1 | $2.8M | Buy |
|
|||||
|
2014
Q4 | $3.04M | Buy |
|
|||||
|
2014
Q3 | $3.22M | Buy |
|
|||||
|
2014
Q2 | $3.25M | Buy |
|
|||||
|
2014
Q1 | $2.97M | Buy |
|
|||||
|
2013
Q4 | $2.34M | Buy |
|
|||||
|
2013
Q3 | $1.42M | Buy |
|
|||||
|
2013
Q2 | $504K | Buy |
|